These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9708599)

  • 41. Medicaid program; Drug Use Review program and electronic claims management system for outpatient drug claims--HCFA. Interim final rule with comment period.
    Fed Regist; 1992 Nov; 57(212):49397-412. PubMed ID: 10122482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The unintended (and costly) effects due to the introduction of an unrestricted reimbursement policy for atypical antipsychotic medications in a Canadian public prescription drug program: 1996/97 to 2005/06.
    O'Reilly DJ; Goeree RA; Tarride JE; James C; Parfrey PS
    Can J Clin Pharmacol; 2009; 16(2):e346-59. PubMed ID: 19531813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medication cost information in a computer-based patient record system. Impact on prescribing in a family medicine clinical practice.
    Ornstein SM; MacFarlane LL; Jenkins RG; Pan Q; Wager KA
    Arch Fam Med; 1999; 8(2):118-21. PubMed ID: 10101981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
    McCombs JS; Ahn J; Tencer T; Shi L
    J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased Use Of Prescription Drugs Reduces Medical Costs In Medicaid Populations.
    Roebuck MC; Dougherty JS; Kaestner R; Miller LM
    Health Aff (Millwood); 2015 Sep; 34(9):1586-93. PubMed ID: 26355062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The demise of Oregon's Medically Needy program: effects of losing prescription drug coverage.
    Zerzan J; Edlund T; Krois L; Smith J
    J Gen Intern Med; 2007 Jun; 22(6):847-51. PubMed ID: 17380369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Universal Health Insurance Coverage in Massachusetts Did Not Change the Trajectory of Arthroplasty Use or Costs.
    Kurtz SM; Lau E; Ong KL; Katz JN; Bozic KJ
    Clin Orthop Relat Res; 2016 May; 474(5):1090-8. PubMed ID: 26683036
    [TBL] [Abstract][Full Text] [Related]  

  • 48. More nonelderly Americans face problems affording prescription drugs.
    Felland LE; Reschovsky JD
    Track Rep; 2009 Jan; (22):1-4. PubMed ID: 19320083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prescribing and drug costs in the province of Ontario.
    Lexchin J
    Int J Health Serv; 1992; 22(3):471-87. PubMed ID: 1644510
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First-year Medicare Part D prescription drug benefits: medication access and continuity among dual eligible psychiatric patients.
    West JC; Wilk JE; Rae DS; Muszynski IL; Rubio-Stipec M; Alter CL; Sanders KE; Crystal S; Regier DA
    J Clin Psychiatry; 2010 Apr; 71(4):400-10. PubMed ID: 19925748
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prescription drug payment policy: past, present, and future.
    Gondek K
    Health Care Financ Rev; 1994; 15(3):1-7. PubMed ID: 10137792
    [TBL] [Abstract][Full Text] [Related]  

  • 52. State Medicaid pharmacy payments and their relation to estimated costs.
    Adams EK; Kreling DH; Gondek K
    Health Care Financ Rev; 1994; 15(3):25-42. PubMed ID: 10137796
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlates of prescription and over-the-counter medication usage among older Mexican Americans: the Hispanic EPESE study. Established Population for the Epidemiologic Study of the Elderly.
    Espino DV; Lichtenstein MJ; Hazuda HP; Fabrizio D; Wood RC; Goodwin J; Stroup-Benham CA; Markides KS
    J Am Geriatr Soc; 1998 Oct; 46(10):1228-34. PubMed ID: 9777904
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prescription analgesic and antidepressant utilization and cost among elderly Medicaid beneficiaries before and after nursing home admission.
    Chu L; Schnelle JF; Osterweil D
    J Am Med Dir Assoc; 2004; 5(2):75-81. PubMed ID: 14984617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost and utilization impacts of oral antihistamines in the California Medi-Cal program.
    Hay JW; Leahy M
    Value Health; 2005; 8(4):506-16. PubMed ID: 16091028
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?
    Cromwell DM; Bass EB; Steinberg EP; Yasui Y; Ravich WJ; Hendrix TR; McLeod SF; Moore RD
    Health Serv Res; 1999 Feb; 33(6):1593-610. PubMed ID: 10029499
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Who bears the burden of Medicaid drug copayment policies?
    Stuart B; Zacker C
    Health Aff (Millwood); 1999; 18(2):201-12. PubMed ID: 10091449
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines.
    Manteuffel M; Williams S; Chen W; Verbrugge RR; Pittman DG; Steinkellner A
    J Womens Health (Larchmt); 2014 Feb; 23(2):112-9. PubMed ID: 24206025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of pharmaceutical cost containment policies on doctors' prescribing behavior: Focus on antibiotics.
    Han E; Chae SM; Kim NS; Park S
    Health Policy; 2015 Sep; 119(9):1245-54. PubMed ID: 26119997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.